Jennifer L. King is a registered patent attorney and is experienced in patent portfolio management in the biotechnology, pharmaceutical, and medical device fields. Jennifer became a patent attorney because she enjoys applying her understanding of diverse technologies to assisting clients to succeed.
Jennifer has represented clients of all sizes. In addition to the preparation and prosecution of patent applications, Jennifer also has broad experience with managing patent portfolios, drafting patent opinions, and patent litigation. Jennifer has over twenty years of law firm experience and has worked on a wide range of patent prosecution matters, opinion drafting, landscape analyses, patentability analyses, and patent enforcement and defense. For example, Jennifer was part of a team that successfully defended the validity and enforceability of certain key patent claims at trial before a U.S. District Court. As another example, Jennifer was part of a team that negotiated a favorable settlement of an interference proceeding. Jennifer also has experience in appellate litigation, litigation before the International Trade Commission, and alternative dispute resolution. Jennifer enjoys translating her litigation experience into drafting and prosecuting strong patents, drafting strong opinions, and meaningful client counseling.
In addition to having earned a B.S. in Biology, Jennifer studied and worked in laboratories for two academic years in a Ph.D. program, with emphasis on genetics, molecular biology, biochemistry, transgenics, immunology, and virology.
Biotechnology / Pharmaceutical / Chemical: antibodies, including antibody therapy and production; immunotherapeutics, including chimeric antigen T cell therapies; pharmaceutical formulations and delivery systems; enzymes; tissue regeneration; manipulation of cells in culture to manufacture products such as nutritional supplements; stem cell production; genetic engineering; and agricultural pesticides.
Medical Devices: vascular balloon catheters; ventilation therapy; spinal alignment; and microarrays and platform devices for biomedical, chemical, and pharmaceutical molecular research and diagnostics.
King and T. Herbert, “Seagate and Opinions of Counsel: Still A Sound Business Practice,” Intellectual Asset Management Magazine: Patents in the USA 2008: 40-43.
- Georgetown University Law Center, J.D., cum laude, 1999
- The George Washington University, B.S. Biology, magna cum laude, 1994.
- District of Columbia, 1999
- United States Patent and Trademark Office, 2000
- United States District Court, District of Columbia
- United States Court of Appeals for the Federal Circuit